nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—Myelosuppression—Vinblastine—germ cell cancer	0.00777	0.055	CcSEcCtD
Ruxolitinib—Myelosuppression—Bleomycin—germ cell cancer	0.00657	0.0465	CcSEcCtD
Ruxolitinib—Myelosuppression—Dactinomycin—germ cell cancer	0.00612	0.0433	CcSEcCtD
Ruxolitinib—Myelosuppression—Ifosfamide—germ cell cancer	0.00561	0.0397	CcSEcCtD
Ruxolitinib—Myelosuppression—Cisplatin—germ cell cancer	0.00484	0.0342	CcSEcCtD
Ruxolitinib—Myelosuppression—Etoposide—germ cell cancer	0.00443	0.0314	CcSEcCtD
Ruxolitinib—PLK1—Teniposide—Etoposide—germ cell cancer	0.00426	0.5	CbGdCrCtD
Ruxolitinib—PLK4—Teniposide—Etoposide—germ cell cancer	0.00426	0.5	CbGdCrCtD
Ruxolitinib—Bone pain—Vinblastine—germ cell cancer	0.00381	0.0269	CcSEcCtD
Ruxolitinib—Herpes zoster—Ifosfamide—germ cell cancer	0.00349	0.0247	CcSEcCtD
Ruxolitinib—Pancytopenia—Vinblastine—germ cell cancer	0.00217	0.0154	CcSEcCtD
Ruxolitinib—Gastrointestinal haemorrhage—Ifosfamide—germ cell cancer	0.00191	0.0135	CcSEcCtD
Ruxolitinib—Haemoglobin—Vinblastine—germ cell cancer	0.00184	0.013	CcSEcCtD
Ruxolitinib—Pancytopenia—Bleomycin—germ cell cancer	0.00183	0.013	CcSEcCtD
Ruxolitinib—Haemorrhage—Vinblastine—germ cell cancer	0.00183	0.013	CcSEcCtD
Ruxolitinib—Weight decreased—Bleomycin—germ cell cancer	0.00175	0.0124	CcSEcCtD
Ruxolitinib—Pancytopenia—Dactinomycin—germ cell cancer	0.00171	0.0121	CcSEcCtD
Ruxolitinib—Neutropenia—Dactinomycin—germ cell cancer	0.00168	0.0119	CcSEcCtD
Ruxolitinib—Herpes zoster—Methotrexate—germ cell cancer	0.00165	0.0117	CcSEcCtD
Ruxolitinib—Gastrointestinal haemorrhage—Cisplatin—germ cell cancer	0.00165	0.0117	CcSEcCtD
Ruxolitinib—Haematuria—Bleomycin—germ cell cancer	0.00164	0.0116	CcSEcCtD
Ruxolitinib—Pancytopenia—Ifosfamide—germ cell cancer	0.00157	0.0111	CcSEcCtD
Ruxolitinib—Haemoglobin—Bleomycin—germ cell cancer	0.00155	0.011	CcSEcCtD
Ruxolitinib—Haemorrhage—Bleomycin—germ cell cancer	0.00155	0.0109	CcSEcCtD
Ruxolitinib—Anaemia—Vinblastine—germ cell cancer	0.00147	0.0104	CcSEcCtD
Ruxolitinib—Infestation NOS—Ifosfamide—germ cell cancer	0.00147	0.0104	CcSEcCtD
Ruxolitinib—Infestation—Ifosfamide—germ cell cancer	0.00147	0.0104	CcSEcCtD
Ruxolitinib—Haematuria—Ifosfamide—germ cell cancer	0.0014	0.00993	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.00139	0.00985	CcSEcCtD
Ruxolitinib—Pancytopenia—Cisplatin—germ cell cancer	0.00135	0.00957	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.00133	0.00942	CcSEcCtD
Ruxolitinib—Haemoglobin—Ifosfamide—germ cell cancer	0.00133	0.0094	CcSEcCtD
Ruxolitinib—Haemorrhage—Ifosfamide—germ cell cancer	0.00132	0.00935	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Vinblastine—germ cell cancer	0.00127	0.00901	CcSEcCtD
Ruxolitinib—Anaemia—Bleomycin—germ cell cancer	0.00124	0.0088	CcSEcCtD
Ruxolitinib—Pancytopenia—Etoposide—germ cell cancer	0.00124	0.00876	CcSEcCtD
Ruxolitinib—Neutropenia—Etoposide—germ cell cancer	0.00122	0.00863	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Cisplatin—germ cell cancer	0.0012	0.00849	CcSEcCtD
Ruxolitinib—Infestation—Etoposide—germ cell cancer	0.00116	0.00823	CcSEcCtD
Ruxolitinib—Infestation NOS—Etoposide—germ cell cancer	0.00116	0.00823	CcSEcCtD
Ruxolitinib—Anaemia—Dactinomycin—germ cell cancer	0.00116	0.00821	CcSEcCtD
Ruxolitinib—Malnutrition—Ifosfamide—germ cell cancer	0.00115	0.00814	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Etoposide—germ cell cancer	0.0011	0.00778	CcSEcCtD
Ruxolitinib—Infection—Bleomycin—germ cell cancer	0.00109	0.00772	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Bleomycin—germ cell cancer	0.00108	0.00761	CcSEcCtD
Ruxolitinib—Anaemia—Ifosfamide—germ cell cancer	0.00106	0.00752	CcSEcCtD
Ruxolitinib—Infection—Dactinomycin—germ cell cancer	0.00102	0.0072	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Dactinomycin—germ cell cancer	0.001	0.0071	CcSEcCtD
Ruxolitinib—Malnutrition—Cisplatin—germ cell cancer	0.000992	0.00702	CcSEcCtD
Ruxolitinib—Flatulence—Cisplatin—germ cell cancer	0.000977	0.00692	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000973	0.00688	CcSEcCtD
Ruxolitinib—Asthenia—Vinblastine—germ cell cancer	0.000933	0.0066	CcSEcCtD
Ruxolitinib—Infection—Ifosfamide—germ cell cancer	0.000933	0.0066	CcSEcCtD
Ruxolitinib—Nervous system disorder—Ifosfamide—germ cell cancer	0.000921	0.00652	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000919	0.00651	CcSEcCtD
Ruxolitinib—Anaemia—Cisplatin—germ cell cancer	0.000917	0.00649	CcSEcCtD
Ruxolitinib—Skin disorder—Ifosfamide—germ cell cancer	0.000912	0.00645	CcSEcCtD
Ruxolitinib—Fatigue—Dactinomycin—germ cell cancer	0.000883	0.00625	CcSEcCtD
Ruxolitinib—Body temperature increased—Bleomycin—germ cell cancer	0.000868	0.00615	CcSEcCtD
Ruxolitinib—Dizziness—Vinblastine—germ cell cancer	0.00086	0.00609	CcSEcCtD
Ruxolitinib—RET—decidua—germ cell cancer	0.000843	0.00178	CbGeAlD
Ruxolitinib—CLK2—female gonad—germ cell cancer	0.000842	0.00178	CbGeAlD
Ruxolitinib—JAK2—telencephalon—germ cell cancer	0.00084	0.00177	CbGeAlD
Ruxolitinib—JAK1—testis—germ cell cancer	0.00084	0.00177	CbGeAlD
Ruxolitinib—DCLK1—testis—germ cell cancer	0.00084	0.00177	CbGeAlD
Ruxolitinib—Anaemia—Etoposide—germ cell cancer	0.00084	0.00594	CcSEcCtD
Ruxolitinib—BMPR2—midbrain—germ cell cancer	0.000839	0.00177	CbGeAlD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000838	0.00593	CcSEcCtD
Ruxolitinib—PLK4—testis—germ cell cancer	0.000835	0.00176	CbGeAlD
Ruxolitinib—TAOK3—brainstem—germ cell cancer	0.000832	0.00176	CbGeAlD
Ruxolitinib—STK16—endocrine gland—germ cell cancer	0.000827	0.00175	CbGeAlD
Ruxolitinib—HIPK2—endocrine gland—germ cell cancer	0.000823	0.00174	CbGeAlD
Ruxolitinib—CAMK2G—medulla oblongata—germ cell cancer	0.000822	0.00173	CbGeAlD
Ruxolitinib—PLK3—brain—germ cell cancer	0.000822	0.00173	CbGeAlD
Ruxolitinib—CAMK1D—testis—germ cell cancer	0.00082	0.00173	CbGeAlD
Ruxolitinib—STK16—head—germ cell cancer	0.000816	0.00172	CbGeAlD
Ruxolitinib—ROCK1—female gonad—germ cell cancer	0.000816	0.00172	CbGeAlD
Ruxolitinib—PHKG2—testis—germ cell cancer	0.000815	0.00172	CbGeAlD
Ruxolitinib—Headache—Vinblastine—germ cell cancer	0.000815	0.00577	CcSEcCtD
Ruxolitinib—LRRK2—medulla oblongata—germ cell cancer	0.000814	0.00172	CbGeAlD
Ruxolitinib—NUAK2—adrenal gland—germ cell cancer	0.000812	0.00172	CbGeAlD
Ruxolitinib—HIPK2—head—germ cell cancer	0.000812	0.00171	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00081	0.00574	CcSEcCtD
Ruxolitinib—TAOK3—eye—germ cell cancer	0.00081	0.00171	CbGeAlD
Ruxolitinib—Body temperature increased—Dactinomycin—germ cell cancer	0.00081	0.00573	CcSEcCtD
Ruxolitinib—Fatigue—Ifosfamide—germ cell cancer	0.000809	0.00573	CcSEcCtD
Ruxolitinib—Infection—Cisplatin—germ cell cancer	0.000804	0.00569	CcSEcCtD
Ruxolitinib—TAOK3—retina—germ cell cancer	0.000803	0.0017	CbGeAlD
Ruxolitinib—JAK2—skin of body—germ cell cancer	0.000802	0.00169	CbGeAlD
Ruxolitinib—DAPK2—testis—germ cell cancer	0.000802	0.00169	CbGeAlD
Ruxolitinib—JAK2—decidua—germ cell cancer	0.000796	0.00168	CbGeAlD
Ruxolitinib—DYRK1A—female gonad—germ cell cancer	0.000796	0.00168	CbGeAlD
Ruxolitinib—MAP3K19—head—germ cell cancer	0.000796	0.00168	CbGeAlD
Ruxolitinib—PLK3—lymph node—germ cell cancer	0.000794	0.00168	CbGeAlD
Ruxolitinib—Nervous system disorder—Cisplatin—germ cell cancer	0.000794	0.00562	CcSEcCtD
Ruxolitinib—LTK—brain—germ cell cancer	0.000793	0.00168	CbGeAlD
Ruxolitinib—BMPR2—female gonad—germ cell cancer	0.000792	0.00167	CbGeAlD
Ruxolitinib—MAP3K2—gonad—germ cell cancer	0.000792	0.00167	CbGeAlD
Ruxolitinib—Thrombocytopenia—Cisplatin—germ cell cancer	0.000792	0.00561	CcSEcCtD
Ruxolitinib—DAPK3—endocrine gland—germ cell cancer	0.00079	0.00167	CbGeAlD
Ruxolitinib—STK16—testis—germ cell cancer	0.000789	0.00167	CbGeAlD
Ruxolitinib—Asthenia—Bleomycin—germ cell cancer	0.000788	0.00558	CcSEcCtD
Ruxolitinib—MAP3K2—uterus—germ cell cancer	0.000787	0.00166	CbGeAlD
Ruxolitinib—Skin disorder—Cisplatin—germ cell cancer	0.000786	0.00556	CcSEcCtD
Ruxolitinib—NUAK2—bone marrow—germ cell cancer	0.000786	0.00166	CbGeAlD
Ruxolitinib—HIPK2—testis—germ cell cancer	0.000784	0.00166	CbGeAlD
Ruxolitinib—CLK2—endocrine gland—germ cell cancer	0.000783	0.00165	CbGeAlD
Ruxolitinib—JAK3—cerebellum—germ cell cancer	0.000781	0.00165	CbGeAlD
Ruxolitinib—DAPK3—head—germ cell cancer	0.00078	0.00165	CbGeAlD
Ruxolitinib—MAP3K7—uterus—germ cell cancer	0.00078	0.00165	CbGeAlD
Ruxolitinib—Pruritus—Bleomycin—germ cell cancer	0.000777	0.0055	CcSEcCtD
Ruxolitinib—DCLK1—cerebellum—germ cell cancer	0.000776	0.00164	CbGeAlD
Ruxolitinib—JAK1—cerebellum—germ cell cancer	0.000776	0.00164	CbGeAlD
Ruxolitinib—MAP3K3—skin of body—germ cell cancer	0.000773	0.00163	CbGeAlD
Ruxolitinib—CLK2—head—germ cell cancer	0.000773	0.00163	CbGeAlD
Ruxolitinib—MAP3K19—testis—germ cell cancer	0.000768	0.00162	CbGeAlD
Ruxolitinib—CAMK1—brain—germ cell cancer	0.000768	0.00162	CbGeAlD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000768	0.00544	CcSEcCtD
Ruxolitinib—MAP3K3—decidua—germ cell cancer	0.000768	0.00162	CbGeAlD
Ruxolitinib—LTK—lymph node—germ cell cancer	0.000767	0.00162	CbGeAlD
Ruxolitinib—MAP3K7—pituitary gland—germ cell cancer	0.000766	0.00162	CbGeAlD
Ruxolitinib—TYK2—uterus—germ cell cancer	0.000766	0.00162	CbGeAlD
Ruxolitinib—MKNK2—gonad—germ cell cancer	0.000761	0.00161	CbGeAlD
Ruxolitinib—CAMK2G—adrenal gland—germ cell cancer	0.000761	0.00161	CbGeAlD
Ruxolitinib—BMP2K—adrenal gland—germ cell cancer	0.000761	0.00161	CbGeAlD
Ruxolitinib—ROCK1—endocrine gland—germ cell cancer	0.000759	0.0016	CbGeAlD
Ruxolitinib—CAMK1D—cerebellum—germ cell cancer	0.000757	0.0016	CbGeAlD
Ruxolitinib—NUAK2—female gonad—germ cell cancer	0.000757	0.0016	CbGeAlD
Ruxolitinib—MKNK2—uterus—germ cell cancer	0.000756	0.0016	CbGeAlD
Ruxolitinib—LRRK2—adrenal gland—germ cell cancer	0.000754	0.00159	CbGeAlD
Ruxolitinib—DAPK3—testis—germ cell cancer	0.000754	0.00159	CbGeAlD
Ruxolitinib—PHKG2—cerebellum—germ cell cancer	0.000753	0.00159	CbGeAlD
Ruxolitinib—TYK2—pituitary gland—germ cell cancer	0.000752	0.00159	CbGeAlD
Ruxolitinib—CAMK2G—midbrain—germ cell cancer	0.000751	0.00159	CbGeAlD
Ruxolitinib—BMP2K—midbrain—germ cell cancer	0.000751	0.00159	CbGeAlD
Ruxolitinib—ROCK1—head—germ cell cancer	0.000749	0.00158	CbGeAlD
Ruxolitinib—CLK2—testis—germ cell cancer	0.000747	0.00158	CbGeAlD
Ruxolitinib—MARK2—brain—germ cell cancer	0.000746	0.00158	CbGeAlD
Ruxolitinib—LRRK2—midbrain—germ cell cancer	0.000744	0.00157	CbGeAlD
Ruxolitinib—CAMK1—lymph node—germ cell cancer	0.000743	0.00157	CbGeAlD
Ruxolitinib—MKNK2—pituitary gland—germ cell cancer	0.000742	0.00157	CbGeAlD
Ruxolitinib—Body temperature increased—Ifosfamide—germ cell cancer	0.000742	0.00525	CcSEcCtD
Ruxolitinib—Pancytopenia—Methotrexate—germ cell cancer	0.000742	0.00525	CcSEcCtD
Ruxolitinib—DAPK2—cerebellum—germ cell cancer	0.00074	0.00156	CbGeAlD
Ruxolitinib—DYRK1A—endocrine gland—germ cell cancer	0.00074	0.00156	CbGeAlD
Ruxolitinib—MAP3K7—medulla oblongata—germ cell cancer	0.000739	0.00156	CbGeAlD
Ruxolitinib—TAOK3—telencephalon—germ cell cancer	0.000738	0.00156	CbGeAlD
Ruxolitinib—BMPR2—endocrine gland—germ cell cancer	0.000737	0.00156	CbGeAlD
Ruxolitinib—Infection—Etoposide—germ cell cancer	0.000737	0.00521	CcSEcCtD
Ruxolitinib—BMP2K—bone marrow—germ cell cancer	0.000736	0.00155	CbGeAlD
Ruxolitinib—CAMK2G—bone marrow—germ cell cancer	0.000736	0.00155	CbGeAlD
Ruxolitinib—Asthenia—Dactinomycin—germ cell cancer	0.000735	0.0052	CcSEcCtD
Ruxolitinib—BMP2K—spinal cord—germ cell cancer	0.000733	0.00155	CbGeAlD
Ruxolitinib—CAMK2G—spinal cord—germ cell cancer	0.000733	0.00155	CbGeAlD
Ruxolitinib—DYRK1A—head—germ cell cancer	0.000731	0.00154	CbGeAlD
Ruxolitinib—Neutropenia—Methotrexate—germ cell cancer	0.00073	0.00517	CcSEcCtD
Ruxolitinib—LRRK2—bone marrow—germ cell cancer	0.000729	0.00154	CbGeAlD
Ruxolitinib—STK16—cerebellum—germ cell cancer	0.000728	0.00154	CbGeAlD
Ruxolitinib—BMPR2—head—germ cell cancer	0.000728	0.00154	CbGeAlD
Ruxolitinib—LRRK2—spinal cord—germ cell cancer	0.000726	0.00153	CbGeAlD
Ruxolitinib—Thrombocytopenia—Etoposide—germ cell cancer	0.000726	0.00514	CcSEcCtD
Ruxolitinib—TYK2—medulla oblongata—germ cell cancer	0.000726	0.00153	CbGeAlD
Ruxolitinib—HIPK2—cerebellum—germ cell cancer	0.000724	0.00153	CbGeAlD
Ruxolitinib—RET—pituitary gland—germ cell cancer	0.000724	0.00153	CbGeAlD
Ruxolitinib—ROCK1—testis—germ cell cancer	0.000724	0.00153	CbGeAlD
Ruxolitinib—MARK2—lymph node—germ cell cancer	0.000721	0.00152	CbGeAlD
Ruxolitinib—Skin disorder—Etoposide—germ cell cancer	0.00072	0.0051	CcSEcCtD
Ruxolitinib—MKNK2—medulla oblongata—germ cell cancer	0.000716	0.00151	CbGeAlD
Ruxolitinib—CAMK2G—female gonad—germ cell cancer	0.000709	0.0015	CbGeAlD
Ruxolitinib—BMP2K—female gonad—germ cell cancer	0.000709	0.0015	CbGeAlD
Ruxolitinib—DYRK1A—testis—germ cell cancer	0.000706	0.00149	CbGeAlD
Ruxolitinib—BMPR2—testis—germ cell cancer	0.000703	0.00148	CbGeAlD
Ruxolitinib—LRRK2—female gonad—germ cell cancer	0.000703	0.00148	CbGeAlD
Ruxolitinib—JAK2—gonad—germ cell cancer	0.000701	0.00148	CbGeAlD
Ruxolitinib—TAOK3—decidua—germ cell cancer	0.0007	0.00148	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000699	0.00495	CcSEcCtD
Ruxolitinib—RET—medulla oblongata—germ cell cancer	0.000699	0.00148	CbGeAlD
Ruxolitinib—Infestation NOS—Methotrexate—germ cell cancer	0.000696	0.00493	CcSEcCtD
Ruxolitinib—Infestation—Methotrexate—germ cell cancer	0.000696	0.00493	CcSEcCtD
Ruxolitinib—DAPK3—cerebellum—germ cell cancer	0.000696	0.00147	CbGeAlD
Ruxolitinib—MAP3K2—adrenal gland—germ cell cancer	0.000691	0.00146	CbGeAlD
Ruxolitinib—TAOK2—brain—germ cell cancer	0.00069	0.00146	CbGeAlD
Ruxolitinib—CLK2—cerebellum—germ cell cancer	0.00069	0.00146	CbGeAlD
Ruxolitinib—JAK2—pituitary gland—germ cell cancer	0.000684	0.00144	CbGeAlD
Ruxolitinib—MAP3K7—adrenal gland—germ cell cancer	0.000684	0.00144	CbGeAlD
Ruxolitinib—MAP3K3—gonad—germ cell cancer	0.000676	0.00143	CbGeAlD
Ruxolitinib—MAP3K7—midbrain—germ cell cancer	0.000675	0.00143	CbGeAlD
Ruxolitinib—Asthenia—Ifosfamide—germ cell cancer	0.000674	0.00477	CcSEcCtD
Ruxolitinib—TYK2—adrenal gland—germ cell cancer	0.000672	0.00142	CbGeAlD
Ruxolitinib—NUAK2—testis—germ cell cancer	0.000672	0.00142	CbGeAlD
Ruxolitinib—MAP3K2—bone marrow—germ cell cancer	0.000668	0.00141	CbGeAlD
Ruxolitinib—TAOK2—lymph node—germ cell cancer	0.000667	0.00141	CbGeAlD
Ruxolitinib—Pruritus—Ifosfamide—germ cell cancer	0.000664	0.0047	CcSEcCtD
Ruxolitinib—Haematuria—Methotrexate—germ cell cancer	0.000664	0.0047	CcSEcCtD
Ruxolitinib—TYK2—midbrain—germ cell cancer	0.000663	0.0014	CbGeAlD
Ruxolitinib—IRAK1—adrenal gland—germ cell cancer	0.000663	0.0014	CbGeAlD
Ruxolitinib—MKNK2—adrenal gland—germ cell cancer	0.000663	0.0014	CbGeAlD
Ruxolitinib—MAP3K7—bone marrow—germ cell cancer	0.000662	0.0014	CbGeAlD
Ruxolitinib—JAK2—medulla oblongata—germ cell cancer	0.00066	0.00139	CbGeAlD
Ruxolitinib—CAMK2G—endocrine gland—germ cell cancer	0.00066	0.00139	CbGeAlD
Ruxolitinib—BMP2K—endocrine gland—germ cell cancer	0.00066	0.00139	CbGeAlD
Ruxolitinib—MAP3K3—pituitary gland—germ cell cancer	0.000659	0.00139	CbGeAlD
Ruxolitinib—MAP3K7—spinal cord—germ cell cancer	0.000659	0.00139	CbGeAlD
Ruxolitinib—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000659	0.00466	CcSEcCtD
Ruxolitinib—Epistaxis—Methotrexate—germ cell cancer	0.000657	0.00465	CcSEcCtD
Ruxolitinib—MKNK2—midbrain—germ cell cancer	0.000655	0.00138	CbGeAlD
Ruxolitinib—IRAK1—midbrain—germ cell cancer	0.000655	0.00138	CbGeAlD
Ruxolitinib—LRRK2—endocrine gland—germ cell cancer	0.000654	0.00138	CbGeAlD
Ruxolitinib—DYRK1A—cerebellum—germ cell cancer	0.000652	0.00138	CbGeAlD
Ruxolitinib—BMP2K—head—germ cell cancer	0.000651	0.00137	CbGeAlD
Ruxolitinib—CAMK2G—head—germ cell cancer	0.000651	0.00137	CbGeAlD
Ruxolitinib—TYK2—bone marrow—germ cell cancer	0.00065	0.00137	CbGeAlD
Ruxolitinib—BMPR2—cerebellum—germ cell cancer	0.000649	0.00137	CbGeAlD
Ruxolitinib—TYK2—spinal cord—germ cell cancer	0.000647	0.00137	CbGeAlD
Ruxolitinib—RET—adrenal gland—germ cell cancer	0.000647	0.00137	CbGeAlD
Ruxolitinib—LRRK2—head—germ cell cancer	0.000645	0.00136	CbGeAlD
Ruxolitinib—MAP3K2—female gonad—germ cell cancer	0.000644	0.00136	CbGeAlD
Ruxolitinib—IRAK1—bone marrow—germ cell cancer	0.000641	0.00135	CbGeAlD
Ruxolitinib—MKNK2—bone marrow—germ cell cancer	0.000641	0.00135	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00064	0.00453	CcSEcCtD
Ruxolitinib—Body temperature increased—Cisplatin—germ cell cancer	0.00064	0.00453	CcSEcCtD
Ruxolitinib—Fatigue—Etoposide—germ cell cancer	0.000639	0.00452	CcSEcCtD
Ruxolitinib—MKNK2—spinal cord—germ cell cancer	0.000639	0.00135	CbGeAlD
Ruxolitinib—RET—midbrain—germ cell cancer	0.000638	0.00135	CbGeAlD
Ruxolitinib—MAP3K7—female gonad—germ cell cancer	0.000638	0.00135	CbGeAlD
Ruxolitinib—MAP3K3—medulla oblongata—germ cell cancer	0.000636	0.00134	CbGeAlD
Ruxolitinib—JAK3—brain—germ cell cancer	0.000634	0.00134	CbGeAlD
Ruxolitinib—DCLK1—brain—germ cell cancer	0.00063	0.00133	CbGeAlD
Ruxolitinib—JAK1—brain—germ cell cancer	0.00063	0.00133	CbGeAlD
Ruxolitinib—CAMK2G—testis—germ cell cancer	0.000629	0.00133	CbGeAlD
Ruxolitinib—BMP2K—testis—germ cell cancer	0.000629	0.00133	CbGeAlD
Ruxolitinib—Haemoglobin—Methotrexate—germ cell cancer	0.000628	0.00445	CcSEcCtD
Ruxolitinib—TYK2—female gonad—germ cell cancer	0.000626	0.00132	CbGeAlD
Ruxolitinib—PLK4—brain—germ cell cancer	0.000626	0.00132	CbGeAlD
Ruxolitinib—Haemorrhage—Methotrexate—germ cell cancer	0.000625	0.00442	CcSEcCtD
Ruxolitinib—LRRK2—testis—germ cell cancer	0.000623	0.00132	CbGeAlD
Ruxolitinib—RET—spinal cord—germ cell cancer	0.000623	0.00132	CbGeAlD
Ruxolitinib—Dizziness—Ifosfamide—germ cell cancer	0.000621	0.00439	CcSEcCtD
Ruxolitinib—NUAK2—cerebellum—germ cell cancer	0.00062	0.00131	CbGeAlD
Ruxolitinib—MKNK2—female gonad—germ cell cancer	0.000618	0.00131	CbGeAlD
Ruxolitinib—IRAK1—female gonad—germ cell cancer	0.000618	0.00131	CbGeAlD
Ruxolitinib—CAMK1D—brain—germ cell cancer	0.000615	0.0013	CbGeAlD
Ruxolitinib—JAK3—lymph node—germ cell cancer	0.000613	0.00129	CbGeAlD
Ruxolitinib—TAOK3—uterus—germ cell cancer	0.000612	0.00129	CbGeAlD
Ruxolitinib—PHKG2—brain—germ cell cancer	0.000612	0.00129	CbGeAlD
Ruxolitinib—JAK2—adrenal gland—germ cell cancer	0.000611	0.00129	CbGeAlD
Ruxolitinib—JAK1—lymph node—germ cell cancer	0.000609	0.00129	CbGeAlD
Ruxolitinib—DCLK1—lymph node—germ cell cancer	0.000609	0.00129	CbGeAlD
Ruxolitinib—PLK4—lymph node—germ cell cancer	0.000605	0.00128	CbGeAlD
Ruxolitinib—DAPK2—brain—germ cell cancer	0.000601	0.00127	CbGeAlD
Ruxolitinib—TAOK3—pituitary gland—germ cell cancer	0.000601	0.00127	CbGeAlD
Ruxolitinib—MAP3K2—endocrine gland—germ cell cancer	0.000599	0.00126	CbGeAlD
Ruxolitinib—CAMK1D—lymph node—germ cell cancer	0.000594	0.00126	CbGeAlD
Ruxolitinib—STK16—brain—germ cell cancer	0.000592	0.00125	CbGeAlD
Ruxolitinib—JAK2—bone marrow—germ cell cancer	0.000591	0.00125	CbGeAlD
Ruxolitinib—MAP3K2—head—germ cell cancer	0.000591	0.00125	CbGeAlD
Ruxolitinib—PHKG2—lymph node—germ cell cancer	0.000591	0.00125	CbGeAlD
Ruxolitinib—MAP3K3—adrenal gland—germ cell cancer	0.000589	0.00124	CbGeAlD
Ruxolitinib—JAK2—spinal cord—germ cell cancer	0.000589	0.00124	CbGeAlD
Ruxolitinib—HIPK2—brain—germ cell cancer	0.000588	0.00124	CbGeAlD
Ruxolitinib—Body temperature increased—Etoposide—germ cell cancer	0.000586	0.00415	CcSEcCtD
Ruxolitinib—TYK2—endocrine gland—germ cell cancer	0.000583	0.00123	CbGeAlD
Ruxolitinib—MAP3K3—midbrain—germ cell cancer	0.000582	0.00123	CbGeAlD
Ruxolitinib—DAPK2—lymph node—germ cell cancer	0.000581	0.00123	CbGeAlD
Ruxolitinib—CAMK2G—cerebellum—germ cell cancer	0.000581	0.00123	CbGeAlD
Ruxolitinib—BMP2K—cerebellum—germ cell cancer	0.000581	0.00123	CbGeAlD
Ruxolitinib—Asthenia—Cisplatin—germ cell cancer	0.000581	0.00411	CcSEcCtD
Ruxolitinib—TAOK3—medulla oblongata—germ cell cancer	0.00058	0.00123	CbGeAlD
Ruxolitinib—MAP3K19—brain—germ cell cancer	0.000576	0.00122	CbGeAlD
Ruxolitinib—LRRK2—cerebellum—germ cell cancer	0.000576	0.00122	CbGeAlD
Ruxolitinib—TYK2—head—germ cell cancer	0.000575	0.00121	CbGeAlD
Ruxolitinib—MKNK2—endocrine gland—germ cell cancer	0.000575	0.00121	CbGeAlD
Ruxolitinib—STK16—lymph node—germ cell cancer	0.000572	0.00121	CbGeAlD
Ruxolitinib—MAP3K2—testis—germ cell cancer	0.000571	0.00121	CbGeAlD
Ruxolitinib—JAK2—female gonad—germ cell cancer	0.00057	0.0012	CbGeAlD
Ruxolitinib—MAP3K3—bone marrow—germ cell cancer	0.00057	0.0012	CbGeAlD
Ruxolitinib—HIPK2—lymph node—germ cell cancer	0.000569	0.0012	CbGeAlD
Ruxolitinib—MKNK2—head—germ cell cancer	0.000568	0.0012	CbGeAlD
Ruxolitinib—MAP3K3—spinal cord—germ cell cancer	0.000567	0.0012	CbGeAlD
Ruxolitinib—MAP3K7—testis—germ cell cancer	0.000566	0.00119	CbGeAlD
Ruxolitinib—DAPK3—brain—germ cell cancer	0.000565	0.00119	CbGeAlD
Ruxolitinib—RET—endocrine gland—germ cell cancer	0.000561	0.00118	CbGeAlD
Ruxolitinib—CLK2—brain—germ cell cancer	0.00056	0.00118	CbGeAlD
Ruxolitinib—TYK2—testis—germ cell cancer	0.000556	0.00117	CbGeAlD
Ruxolitinib—RET—head—germ cell cancer	0.000554	0.00117	CbGeAlD
Ruxolitinib—MAP3K3—female gonad—germ cell cancer	0.000549	0.00116	CbGeAlD
Ruxolitinib—IRAK1—testis—germ cell cancer	0.000548	0.00116	CbGeAlD
Ruxolitinib—MKNK2—testis—germ cell cancer	0.000548	0.00116	CbGeAlD
Ruxolitinib—DAPK3—lymph node—germ cell cancer	0.000546	0.00115	CbGeAlD
Ruxolitinib—Malnutrition—Methotrexate—germ cell cancer	0.000544	0.00385	CcSEcCtD
Ruxolitinib—ROCK1—brain—germ cell cancer	0.000543	0.00115	CbGeAlD
Ruxolitinib—CLK2—lymph node—germ cell cancer	0.000541	0.00114	CbGeAlD
Ruxolitinib—TAOK3—adrenal gland—germ cell cancer	0.000537	0.00113	CbGeAlD
Ruxolitinib—RET—testis—germ cell cancer	0.000535	0.00113	CbGeAlD
Ruxolitinib—Asthenia—Etoposide—germ cell cancer	0.000532	0.00377	CcSEcCtD
Ruxolitinib—TAOK3—midbrain—germ cell cancer	0.00053	0.00112	CbGeAlD
Ruxolitinib—JAK2—endocrine gland—germ cell cancer	0.00053	0.00112	CbGeAlD
Ruxolitinib—DYRK1A—brain—germ cell cancer	0.000529	0.00112	CbGeAlD
Ruxolitinib—MAP3K2—cerebellum—germ cell cancer	0.000527	0.00111	CbGeAlD
Ruxolitinib—BMPR2—brain—germ cell cancer	0.000527	0.00111	CbGeAlD
Ruxolitinib—Pruritus—Etoposide—germ cell cancer	0.000525	0.00371	CcSEcCtD
Ruxolitinib—JAK2—head—germ cell cancer	0.000523	0.0011	CbGeAlD
Ruxolitinib—MAP3K7—cerebellum—germ cell cancer	0.000523	0.0011	CbGeAlD
Ruxolitinib—TAOK3—bone marrow—germ cell cancer	0.00052	0.0011	CbGeAlD
Ruxolitinib—TAOK3—spinal cord—germ cell cancer	0.000517	0.00109	CbGeAlD
Ruxolitinib—TYK2—cerebellum—germ cell cancer	0.000513	0.00108	CbGeAlD
Ruxolitinib—DYRK1A—lymph node—germ cell cancer	0.000512	0.00108	CbGeAlD
Ruxolitinib—MAP3K3—endocrine gland—germ cell cancer	0.000511	0.00108	CbGeAlD
Ruxolitinib—BMPR2—lymph node—germ cell cancer	0.000509	0.00108	CbGeAlD
Ruxolitinib—MKNK2—cerebellum—germ cell cancer	0.000506	0.00107	CbGeAlD
Ruxolitinib—IRAK1—cerebellum—germ cell cancer	0.000506	0.00107	CbGeAlD
Ruxolitinib—JAK2—testis—germ cell cancer	0.000505	0.00107	CbGeAlD
Ruxolitinib—MAP3K3—head—germ cell cancer	0.000504	0.00106	CbGeAlD
Ruxolitinib—NUAK2—brain—germ cell cancer	0.000504	0.00106	CbGeAlD
Ruxolitinib—Anaemia—Methotrexate—germ cell cancer	0.000503	0.00356	CcSEcCtD
Ruxolitinib—TAOK3—female gonad—germ cell cancer	0.000501	0.00106	CbGeAlD
Ruxolitinib—RET—cerebellum—germ cell cancer	0.000494	0.00104	CbGeAlD
Ruxolitinib—Dizziness—Etoposide—germ cell cancer	0.00049	0.00347	CcSEcCtD
Ruxolitinib—MAP3K3—testis—germ cell cancer	0.000487	0.00103	CbGeAlD
Ruxolitinib—NUAK2—lymph node—germ cell cancer	0.000487	0.00103	CbGeAlD
Ruxolitinib—CAMK2G—brain—germ cell cancer	0.000472	0.000996	CbGeAlD
Ruxolitinib—BMP2K—brain—germ cell cancer	0.000472	0.000996	CbGeAlD
Ruxolitinib—LRRK2—brain—germ cell cancer	0.000468	0.000987	CbGeAlD
Ruxolitinib—JAK2—cerebellum—germ cell cancer	0.000467	0.000986	CbGeAlD
Ruxolitinib—TAOK3—endocrine gland—germ cell cancer	0.000466	0.000983	CbGeAlD
Ruxolitinib—Headache—Etoposide—germ cell cancer	0.000464	0.00329	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00046	0.00326	CcSEcCtD
Ruxolitinib—TAOK3—head—germ cell cancer	0.00046	0.000971	CbGeAlD
Ruxolitinib—CAMK2G—lymph node—germ cell cancer	0.000456	0.000963	CbGeAlD
Ruxolitinib—BMP2K—lymph node—germ cell cancer	0.000456	0.000963	CbGeAlD
Ruxolitinib—LRRK2—lymph node—germ cell cancer	0.000452	0.000954	CbGeAlD
Ruxolitinib—MAP3K3—cerebellum—germ cell cancer	0.00045	0.00095	CbGeAlD
Ruxolitinib—TAOK3—testis—germ cell cancer	0.000444	0.000938	CbGeAlD
Ruxolitinib—Infection—Methotrexate—germ cell cancer	0.000441	0.00312	CcSEcCtD
Ruxolitinib—Nervous system disorder—Methotrexate—germ cell cancer	0.000436	0.00308	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Methotrexate—germ cell cancer	0.000435	0.00308	CcSEcCtD
Ruxolitinib—Skin disorder—Methotrexate—germ cell cancer	0.000431	0.00305	CcSEcCtD
Ruxolitinib—MAP3K2—brain—germ cell cancer	0.000428	0.000905	CbGeAlD
Ruxolitinib—MAP3K7—brain—germ cell cancer	0.000424	0.000896	CbGeAlD
Ruxolitinib—TYK2—brain—germ cell cancer	0.000417	0.00088	CbGeAlD
Ruxolitinib—MAP3K2—lymph node—germ cell cancer	0.000414	0.000874	CbGeAlD
Ruxolitinib—IRAK1—brain—germ cell cancer	0.000411	0.000869	CbGeAlD
Ruxolitinib—MKNK2—brain—germ cell cancer	0.000411	0.000869	CbGeAlD
Ruxolitinib—TAOK3—cerebellum—germ cell cancer	0.00041	0.000866	CbGeAlD
Ruxolitinib—MAP3K7—lymph node—germ cell cancer	0.00041	0.000866	CbGeAlD
Ruxolitinib—TYK2—lymph node—germ cell cancer	0.000403	0.00085	CbGeAlD
Ruxolitinib—RET—brain—germ cell cancer	0.000401	0.000847	CbGeAlD
Ruxolitinib—IRAK1—lymph node—germ cell cancer	0.000397	0.000839	CbGeAlD
Ruxolitinib—MKNK2—lymph node—germ cell cancer	0.000397	0.000839	CbGeAlD
Ruxolitinib—RET—lymph node—germ cell cancer	0.000388	0.000819	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000383	0.00271	CcSEcCtD
Ruxolitinib—Fatigue—Methotrexate—germ cell cancer	0.000383	0.00271	CcSEcCtD
Ruxolitinib—JAK2—brain—germ cell cancer	0.000379	0.000801	CbGeAlD
Ruxolitinib—JAK2—lymph node—germ cell cancer	0.000366	0.000774	CbGeAlD
Ruxolitinib—MAP3K3—brain—germ cell cancer	0.000365	0.000772	CbGeAlD
Ruxolitinib—MAP3K3—lymph node—germ cell cancer	0.000353	0.000746	CbGeAlD
Ruxolitinib—Body temperature increased—Methotrexate—germ cell cancer	0.000351	0.00248	CcSEcCtD
Ruxolitinib—TAOK3—brain—germ cell cancer	0.000333	0.000704	CbGeAlD
Ruxolitinib—TAOK3—lymph node—germ cell cancer	0.000322	0.00068	CbGeAlD
Ruxolitinib—Asthenia—Methotrexate—germ cell cancer	0.000319	0.00226	CcSEcCtD
Ruxolitinib—Pruritus—Methotrexate—germ cell cancer	0.000314	0.00222	CcSEcCtD
Ruxolitinib—Dizziness—Methotrexate—germ cell cancer	0.000294	0.00208	CcSEcCtD
Ruxolitinib—Headache—Methotrexate—germ cell cancer	0.000278	0.00197	CcSEcCtD
Ruxolitinib—CYP3A4—endocrine gland—germ cell cancer	0.000141	0.000299	CbGeAlD
Ruxolitinib—TYK2—Signaling by ERBB2—HRAS—germ cell cancer	8.31e-05	0.000221	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—FGFR3—germ cell cancer	8.28e-05	0.00022	CbGpPWpGaD
Ruxolitinib—TYK2—DAP12 signaling—HRAS—germ cell cancer	8.27e-05	0.00022	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by Insulin receptor—HRAS—germ cell cancer	8.27e-05	0.00022	CbGpPWpGaD
Ruxolitinib—PLK1—Cell Cycle—MYC—germ cell cancer	8.26e-05	0.000219	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—FGFR3—germ cell cancer	8.25e-05	0.000219	CbGpPWpGaD
Ruxolitinib—MAP3K7—MAPK Signaling Pathway—TP53—germ cell cancer	8.23e-05	0.000218	CbGpPWpGaD
Ruxolitinib—MAP3K7—Insulin Signaling—HRAS—germ cell cancer	8.18e-05	0.000217	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—H2AFZ—germ cell cancer	8.12e-05	0.000216	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—KITLG—germ cell cancer	8.09e-05	0.000215	CbGpPWpGaD
Ruxolitinib—MAP3K7—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	7.91e-05	0.00021	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—FGFR3—germ cell cancer	7.85e-05	0.000208	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—H2AFZ—germ cell cancer	7.83e-05	0.000208	CbGpPWpGaD
Ruxolitinib—JAK2—PDGFR-beta signaling pathway—HRAS—germ cell cancer	7.79e-05	0.000207	CbGpPWpGaD
Ruxolitinib—TYK2—DAP12 interactions—HRAS—germ cell cancer	7.78e-05	0.000207	CbGpPWpGaD
Ruxolitinib—TYK2—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	7.78e-05	0.000207	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by FGFR in disease—HRAS—germ cell cancer	7.78e-05	0.000207	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—OXT—germ cell cancer	7.78e-05	0.000207	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—KITLG—germ cell cancer	7.77e-05	0.000206	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by EGFR—HRAS—germ cell cancer	7.71e-05	0.000205	CbGpPWpGaD
Ruxolitinib—PLK4—Cell Cycle—MYC—germ cell cancer	7.71e-05	0.000205	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—FGFR3—germ cell cancer	7.65e-05	0.000203	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by EGFR in Cancer—HRAS—germ cell cancer	7.64e-05	0.000203	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—FGFR3—germ cell cancer	7.62e-05	0.000202	CbGpPWpGaD
Ruxolitinib—JAK2—Factors involved in megakaryocyte development and platelet production—TP53—germ cell cancer	7.61e-05	0.000202	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by PDGF—HRAS—germ cell cancer	7.61e-05	0.000202	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—KIT—germ cell cancer	7.6e-05	0.000202	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—FGFR3—germ cell cancer	7.59e-05	0.000201	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—KIT—germ cell cancer	7.57e-05	0.000201	CbGpPWpGaD
Ruxolitinib—MAP3K7—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	7.55e-05	0.0002	CbGpPWpGaD
Ruxolitinib—HIPK2—Gene Expression—MYC—germ cell cancer	7.54e-05	0.0002	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—FGF4—germ cell cancer	7.49e-05	0.000199	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—KITLG—germ cell cancer	7.47e-05	0.000198	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—OXT—germ cell cancer	7.46e-05	0.000198	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—FGFR3—germ cell cancer	7.41e-05	0.000197	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—FGF4—germ cell cancer	7.4e-05	0.000197	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—FGFR3—germ cell cancer	7.39e-05	0.000196	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—OXT—germ cell cancer	7.34e-05	0.000195	CbGpPWpGaD
Ruxolitinib—JAK1—Cytokine Signaling in Immune system—HRAS—germ cell cancer	7.3e-05	0.000194	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—FGF4—germ cell cancer	7.27e-05	0.000193	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—KIT—germ cell cancer	7.21e-05	0.000191	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—KITLG—germ cell cancer	7.2e-05	0.000191	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by NGF—HRAS—germ cell cancer	7.18e-05	0.000191	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—FGFR3—germ cell cancer	7.1e-05	0.000188	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by SCF-KIT—HRAS—germ cell cancer	7.07e-05	0.000188	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—OXT—germ cell cancer	7.06e-05	0.000188	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—FGF4—germ cell cancer	7.05e-05	0.000187	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—AVP—germ cell cancer	7.04e-05	0.000187	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—KIT—germ cell cancer	7.02e-05	0.000186	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—KIT—germ cell cancer	7e-05	0.000186	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—FGFR3—germ cell cancer	6.99e-05	0.000186	CbGpPWpGaD
Ruxolitinib—MAP3K7—B Cell Activation—HRAS—germ cell cancer	6.99e-05	0.000185	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—KIT—germ cell cancer	6.96e-05	0.000185	CbGpPWpGaD
Ruxolitinib—JAK2—BDNF signaling pathway—HRAS—germ cell cancer	6.96e-05	0.000185	CbGpPWpGaD
Ruxolitinib—TYK2—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	6.89e-05	0.000183	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—KIT—germ cell cancer	6.8e-05	0.000181	CbGpPWpGaD
Ruxolitinib—PLK1—Cell Cycle—TP53—germ cell cancer	6.79e-05	0.00018	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—KIT—germ cell cancer	6.79e-05	0.00018	CbGpPWpGaD
Ruxolitinib—JAK2—Downstream signaling of activated FGFR—HRAS—germ cell cancer	6.77e-05	0.00018	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—FGF4—germ cell cancer	6.71e-05	0.000178	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by ERBB4—HRAS—germ cell cancer	6.66e-05	0.000177	CbGpPWpGaD
Ruxolitinib—TYK2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	6.66e-05	0.000177	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—H2AFZ—germ cell cancer	6.61e-05	0.000175	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—MYC—germ cell cancer	6.58e-05	0.000175	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—TP53—germ cell cancer	6.55e-05	0.000174	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—KIT—germ cell cancer	6.52e-05	0.000173	CbGpPWpGaD
Ruxolitinib—JAK1—Axon guidance—HRAS—germ cell cancer	6.5e-05	0.000173	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—KIT—germ cell cancer	6.42e-05	0.00017	CbGpPWpGaD
Ruxolitinib—ROCK1—Axon guidance—HRAS—germ cell cancer	6.39e-05	0.00017	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—AVP—germ cell cancer	6.39e-05	0.00017	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—FGF4—germ cell cancer	6.37e-05	0.000169	CbGpPWpGaD
Ruxolitinib—JAK2—Downstream signal transduction—HRAS—germ cell cancer	6.36e-05	0.000169	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by FGFR—HRAS—germ cell cancer	6.33e-05	0.000168	CbGpPWpGaD
Ruxolitinib—JAK2—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	6.33e-05	0.000168	CbGpPWpGaD
Ruxolitinib—PLK4—Cell Cycle—TP53—germ cell cancer	6.33e-05	0.000168	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by ERBB2—HRAS—germ cell cancer	6.3e-05	0.000167	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 signaling—HRAS—germ cell cancer	6.27e-05	0.000166	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—HRAS—germ cell cancer	6.27e-05	0.000166	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—FGF4—germ cell cancer	6.26e-05	0.000166	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—KITLG—germ cell cancer	6.15e-05	0.000163	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—KITLG—germ cell cancer	6.08e-05	0.000161	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling by Wnt—MYC—germ cell cancer	6.03e-05	0.00016	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—FGFR3—germ cell cancer	6.01e-05	0.00016	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—H2AFZ—germ cell cancer	5.99e-05	0.000159	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—KITLG—germ cell cancer	5.97e-05	0.000159	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—MYC—germ cell cancer	5.95e-05	0.000158	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—AVP—germ cell cancer	5.94e-05	0.000158	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 interactions—HRAS—germ cell cancer	5.9e-05	0.000157	CbGpPWpGaD
Ruxolitinib—JAK2—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	5.9e-05	0.000157	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by FGFR in disease—HRAS—germ cell cancer	5.9e-05	0.000157	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by EGFR—HRAS—germ cell cancer	5.85e-05	0.000155	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by EGFR in Cancer—HRAS—germ cell cancer	5.79e-05	0.000154	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—KITLG—germ cell cancer	5.79e-05	0.000154	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—FGFR3—germ cell cancer	5.78e-05	0.000153	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by PDGF—HRAS—germ cell cancer	5.77e-05	0.000153	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—H2AFZ—germ cell cancer	5.69e-05	0.000151	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—OXT—germ cell cancer	5.67e-05	0.000151	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—HRAS—germ cell cancer	5.64e-05	0.00015	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—H2AFZ—germ cell cancer	5.59e-05	0.000148	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—HRAS—germ cell cancer	5.55e-05	0.000147	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—FGFR3—germ cell cancer	5.55e-05	0.000147	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—TP53—germ cell cancer	5.53e-05	0.000147	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—KIT—germ cell cancer	5.52e-05	0.000147	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—KITLG—germ cell cancer	5.51e-05	0.000146	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—FGF4—germ cell cancer	5.51e-05	0.000146	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—OXT—germ cell cancer	5.51e-05	0.000146	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by NGF—HRAS—germ cell cancer	5.46e-05	0.000145	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—HRAS—germ cell cancer	5.39e-05	0.000143	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—FGFR3—germ cell cancer	5.35e-05	0.000142	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—OXT—germ cell cancer	5.34e-05	0.000142	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—AVP—germ cell cancer	5.33e-05	0.000142	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—KIT—germ cell cancer	5.3e-05	0.000141	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by NGF—HRAS—germ cell cancer	5.3e-05	0.000141	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—HRAS—germ cell cancer	5.29e-05	0.00014	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—KITLG—germ cell cancer	5.23e-05	0.000139	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—HRAS—germ cell cancer	5.23e-05	0.000139	CbGpPWpGaD
Ruxolitinib—JAK2—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	5.22e-05	0.000139	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—HRAS—germ cell cancer	5.17e-05	0.000137	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—KITLG—germ cell cancer	5.14e-05	0.000137	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—AVP—germ cell cancer	5.11e-05	0.000136	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—KIT—germ cell cancer	5.1e-05	0.000135	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—FGF4—germ cell cancer	5.09e-05	0.000135	CbGpPWpGaD
Ruxolitinib—JAK2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	5.05e-05	0.000134	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—AVP—germ cell cancer	5.03e-05	0.000134	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—KIT—germ cell cancer	4.92e-05	0.000131	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—MYC—germ cell cancer	4.9e-05	0.00013	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—AVP—germ cell cancer	4.84e-05	0.000129	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—FGF4—germ cell cancer	4.84e-05	0.000129	CbGpPWpGaD
Ruxolitinib—TYK2—Axon guidance—HRAS—germ cell cancer	4.8e-05	0.000127	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—TP53—germ cell cancer	4.76e-05	0.000126	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FGF4—germ cell cancer	4.7e-05	0.000125	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—HRAS—germ cell cancer	4.67e-05	0.000124	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—HRAS—germ cell cancer	4.64e-05	0.000123	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—MYC—germ cell cancer	4.61e-05	0.000122	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—FGFR3—germ cell cancer	4.57e-05	0.000121	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—HRAS—germ cell cancer	4.56e-05	0.000121	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FGF4—germ cell cancer	4.56e-05	0.000121	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—HRAS—germ cell cancer	4.55e-05	0.000121	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—H2AFZ—germ cell cancer	4.54e-05	0.000121	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—KITLG—germ cell cancer	4.53e-05	0.00012	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—FGFR3—germ cell cancer	4.52e-05	0.00012	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—FGFR3—germ cell cancer	4.44e-05	0.000118	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—H2AFZ—germ cell cancer	4.32e-05	0.000115	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—FGFR3—germ cell cancer	4.31e-05	0.000114	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—KIT—germ cell cancer	4.2e-05	0.000111	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—H2AFZ—germ cell cancer	4.2e-05	0.000111	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—KITLG—germ cell cancer	4.18e-05	0.000111	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—OXT—germ cell cancer	4.17e-05	0.000111	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—MYC—germ cell cancer	4.17e-05	0.000111	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—KIT—germ cell cancer	4.15e-05	0.00011	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—FGFR3—germ cell cancer	4.1e-05	0.000109	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—HRAS—germ cell cancer	4.1e-05	0.000109	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—HRAS—germ cell cancer	4.09e-05	0.000109	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—KIT—germ cell cancer	4.08e-05	0.000108	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—H2AFZ—germ cell cancer	4.07e-05	0.000108	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—TP53—germ cell cancer	4.02e-05	0.000107	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—HRAS—germ cell cancer	4.02e-05	0.000107	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—KITLG—germ cell cancer	3.98e-05	0.000106	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—KIT—germ cell cancer	3.95e-05	0.000105	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—AVP—germ cell cancer	3.89e-05	0.000103	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—FGFR3—germ cell cancer	3.89e-05	0.000103	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—MYC—germ cell cancer	3.86e-05	0.000103	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—KITLG—germ cell cancer	3.86e-05	0.000103	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—HRAS—germ cell cancer	3.85e-05	0.000102	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—FGFR3—germ cell cancer	3.82e-05	0.000102	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—TP53—germ cell cancer	3.78e-05	0.0001	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—AVP—germ cell cancer	3.77e-05	0.0001	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—KIT—germ cell cancer	3.76e-05	9.99e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—KITLG—germ cell cancer	3.75e-05	9.94e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—AVP—germ cell cancer	3.66e-05	9.72e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—HRAS—germ cell cancer	3.64e-05	9.65e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—HRAS—germ cell cancer	3.62e-05	9.61e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—HRAS—germ cell cancer	3.6e-05	9.55e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—KIT—germ cell cancer	3.57e-05	9.48e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FGF4—germ cell cancer	3.56e-05	9.46e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—KIT—germ cell cancer	3.51e-05	9.32e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—HRAS—germ cell cancer	3.42e-05	9.09e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—TP53—germ cell cancer	3.42e-05	9.08e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—FGFR3—germ cell cancer	3.36e-05	8.93e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—HRAS—germ cell cancer	3.29e-05	8.72e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—HRAS—germ cell cancer	3.27e-05	8.69e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—H2AFZ—germ cell cancer	3.18e-05	8.45e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—HRAS—germ cell cancer	3.11e-05	8.27e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—FGFR3—germ cell cancer	3.11e-05	8.25e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—KIT—germ cell cancer	3.09e-05	8.2e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—HRAS—germ cell cancer	3.04e-05	8.06e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—HRAS—germ cell cancer	3.03e-05	8.06e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—HRAS—germ cell cancer	3.02e-05	8.03e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—HRAS—germ cell cancer	3.01e-05	7.99e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—FGFR3—germ cell cancer	2.96e-05	7.85e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—HRAS—germ cell cancer	2.94e-05	7.81e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—HRAS—germ cell cancer	2.93e-05	7.79e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—KITLG—germ cell cancer	2.93e-05	7.77e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FGFR3—germ cell cancer	2.87e-05	7.62e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—AVP—germ cell cancer	2.86e-05	7.59e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—KIT—germ cell cancer	2.85e-05	7.57e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—HRAS—germ cell cancer	2.82e-05	7.48e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—MYC—germ cell cancer	2.8e-05	7.45e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FGFR3—germ cell cancer	2.78e-05	7.39e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—HRAS—germ cell cancer	2.77e-05	7.36e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—KIT—germ cell cancer	2.71e-05	7.21e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—MYC—germ cell cancer	2.71e-05	7.18e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—TP53—germ cell cancer	2.66e-05	7.07e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—KIT—germ cell cancer	2.63e-05	7e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—HRAS—germ cell cancer	2.61e-05	6.93e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—HRAS—germ cell cancer	2.59e-05	6.89e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—HRAS—germ cell cancer	2.57e-05	6.82e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—KIT—germ cell cancer	2.56e-05	6.79e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—HRAS—germ cell cancer	2.55e-05	6.76e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—HRAS—germ cell cancer	2.39e-05	6.33e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—HRAS—germ cell cancer	2.29e-05	6.08e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MYC—germ cell cancer	2.28e-05	6.06e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TP53—germ cell cancer	2.22e-05	5.9e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—HRAS—germ cell cancer	2.2e-05	5.85e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FGFR3—germ cell cancer	2.17e-05	5.77e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—HRAS—germ cell cancer	2.12e-05	5.64e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC2A3—germ cell cancer	2.1e-05	5.57e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—MYC—germ cell cancer	2.07e-05	5.5e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC22A3—germ cell cancer	2.06e-05	5.48e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—KIT—germ cell cancer	2e-05	5.3e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MYC—germ cell cancer	1.96e-05	5.21e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MYC—germ cell cancer	1.93e-05	5.13e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—HRAS—germ cell cancer	1.93e-05	5.12e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TP53—germ cell cancer	1.87e-05	4.98e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—HRAS—germ cell cancer	1.81e-05	4.82e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—HRAS—germ cell cancer	1.79e-05	4.76e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—HRAS—germ cell cancer	1.76e-05	4.68e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—HRAS—germ cell cancer	1.71e-05	4.54e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.68e-05	4.47e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—HRAS—germ cell cancer	1.63e-05	4.32e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TP53—germ cell cancer	1.61e-05	4.28e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TP53—germ cell cancer	1.59e-05	4.21e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—MYC—germ cell cancer	1.57e-05	4.17e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—HRAS—germ cell cancer	1.54e-05	4.1e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—HRAS—germ cell cancer	1.52e-05	4.03e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MYC—germ cell cancer	1.49e-05	3.97e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—HRAS—germ cell cancer	1.46e-05	3.88e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MYC—germ cell cancer	1.45e-05	3.85e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MYC—germ cell cancer	1.41e-05	3.73e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—HRAS—germ cell cancer	1.33e-05	3.54e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—HRAS—germ cell cancer	1.23e-05	3.27e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TP53—germ cell cancer	1.23e-05	3.26e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TP53—germ cell cancer	1.19e-05	3.16e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HRAS—germ cell cancer	1.17e-05	3.11e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TP53—germ cell cancer	1.15e-05	3.07e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HRAS—germ cell cancer	1.14e-05	3.02e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HRAS—germ cell cancer	1.1e-05	2.93e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MYC—germ cell cancer	1.1e-05	2.92e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TP53—germ cell cancer	9.02e-06	2.4e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HRAS—germ cell cancer	8.63e-06	2.29e-05	CbGpPWpGaD
